Alnylam Pharmaceuticals
ALNY
#651
Rank
$30.08 B
Marketcap
$237.83
Share price
0.48%
Change (1 day)
18.06%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) Fails to deliver data

Key failure to deliver metrics for Alnylam Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alnylam Pharmaceuticals (ALNY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alnylam Pharmaceuticals (ALNY) - since 2013

Volume in USD (price x number of shares), data since 2013

Alnylam Pharmaceuticals (ALNY) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$22.41 M-56.89%
2023$51.99 M-66.55%
2022$0.15 B200.46%
2021$51.74 M-9.83%
2020$57.38 M52.34%
2019$37.66 M46.52%
2018$25.7 M-70.97%
2017$88.54 M191.96%
2016$30.32 M-14.94%
2015$35.65 M68.07%
2014$21.21 M152.1%
2013$8.41 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
$5.07 M$11.68 M๐Ÿ‡บ๐Ÿ‡ธ USA
$6.47 M$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
$2.55 M$23.22 M๐Ÿ‡บ๐Ÿ‡ธ USA
$35.81 M$52.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
$4.32 M$4.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
$27.32 M$79.47 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$31.66 M$76.03 M๐Ÿ‡ซ๐Ÿ‡ท France
$9.01 M$32.3 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel